Announced Wed, 6 Aug · 16:37 IST

Dhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve To adopt the unadited result

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Dhanvantri Jeevan Rekha Ltd, a hospital-based company based in Meerut, has informed BSE that its Board of Directors will meet on Wednesday, 13 August 2025 at 3:00 PM. The main agenda is to consider and approve the unaudited financial results along with the Limited Review Report of the auditors for the quarter ended 30 June 2025 (Q1 FY26). The company has also confirmed that the trading window for dealing in its equity shares is closed from 1 July 2025 until 48 hours after the results are made public. This is a routine regulatory filing under SEBI LODR Regulation 29, and no financial numbers have been disclosed yet.

Likely market impact

This is a standard pre-results announcement with no immediate impact on the stock. Investors should watch for the actual Q1 FY26 numbers on or after 13 August 2025 to gauge the hospital's revenue growth, margins, and profitability trends.